Brief: Interpace Diagnostics Acquires Cancer Genetics' Biopharma Services Business

Interpace Biosciences

15/07/2019 23:20

July 15 (Reuters) - Interpace Diagnostics Group Inc
 IDXG.O :
    * INTERPACE DIAGNOSTICS ACQUIRES CANCER GENETICS’ BIOPHARMA
SERVICES BUSINESS SUPPORTED BY INVESTMENT FROM AMPERSAND CAPITAL
PARTNERS
    * INTERPACE DIAGNOSTICS GROUP INC - DEAL FOR $23.5 MILLION
    * INTERPACE DIAGNOSTICS - PRIVATE EQUITY FIRM IN
DIAGNOSTIC/BIOPHARMA SECTOR, TO INVEST $27 MILLION IN TWO
TRANCHES OF NEWLY ISSUED CONVERTIBLE PREFERRED STOCK
    * INTERPACE DIAGNOSTICS - UNDER TERMS, MADE ADDITIONAL
PAYMENT OF
ABOUT $4.5 MILLION TO CANCER GENETICS

Source text for Eikon:  ID:nGNX6gTnWt 
Further company coverage:  IDXG.O 

 (Reuters.Briefs@thomsonreuters.com)